Ann: Eve Completes 50% Investment in Meluka Health, page-4

Eve Completes 50% Investment in Meluka Health EVE Investments (ASX:EVE), an ASX‐listed technology investment company, is pleased to provide an update on Meluka Health. Completion of Subscription and Shareholder Agreement for 50% Investment in Meluka Health Eve Investments and the founders of Meluka Health have satisfied or waived all the requisite Conditions Precedent to the Term Sheet between the parties (See ASX Release 28 August 2017). The parties have subsequently executed a Subscription and Shareholder Agreement whereby EVE will acquire its 50% interest in Meluka Health. Completion of the transaction and issuance of shares is expected within the next fortnight along with the execution of the option agreements for other key assets including EcoBotanicals and the Jendale and Robyndale tea tree plantations. Meluka Health holds a 100% stake in honey production company Medic Honey which will be selling multiple honey products including Melaleuca tea tree honey (Meluka Honey), a hemp seed honey and a Melaleuca medicinal serum. Medic Honey is also planning to produce a Cannabis honey and a Bee Hive Health product following completion of research on these products. Ben Rohr, Investment Director of Eve Investments, said: “Eve Investments is pleased to complete its investment in Meluka Health. We are very excited to now focus on the commercialisation of these great honey and bee health products and support the company in what is expected to be a rapid growth phase. There is strong demand for honey, hemp and cannabis related products and the portfolio being developed by Meluka Health will provide EVE with excellent exposure to this sector.”